AMANDA ROBERTSON: Open Payments
NPI 1265023964 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,810 in 142 payments from 23 companies in 2025. Trend: 2023 $2,178 · 2024 $2,334 · 2025 $2,810
Food & beverage: $2,810
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $760 |
| Amgen Inc. | 20 | $316 |
| Novartis Pharmaceuticals Corporation | 12 | $284 |
| Janssen Biotech, Inc. | 17 | $241 |
| GlaxoSmithKline, LLC. | 8 | $157 |
| UCB, Inc. | 9 | $156 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Lilly USA, LLC | 4 | $109 |
| E.R. Squibb & Sons, L.L.C. | 6 | $105 |
| TerSera Therapeutics LLC | 3 | $90 |
Products named: RINVOQ, COSENTYX, TREMFYA, SKYRIZI, BENLYSTA, Bimzelx, SAPHNELO, UPLIZNA.
Industry payments across SC — which companies pay providers there.
